Acadia Healthcare Company, Inc. (ACHC) Financial Ratios
15 years of historical data (2011–2025) · Healthcare · Medical - Care Facilities
EV/EBITDA
↓
8.33
↓-27% vs avg
5yr avg: 11.42
30Y Low6.6·High21.4
P/FCF
↑
N/A
—
5yr avg: 105.63
30Y Low10.1·High185.1
P/B Ratio
↓
1.05
↓-41% vs avg
5yr avg: 1.79
30Y Low0.6·High4.9
ROE
↓
-41.4%
↑-1257% vs avg
5yr avg: -3.0%
30Y Low-41%·High12%
Debt/EBITDA
↑
4.60
↑+45% vs avg
5yr avg: 3.16
30Y Low2.4·High7.5
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
ACHC Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Acadia Healthcare Company, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.3B | $1.3B | $3.7B | $7.1B | $7.5B | $5.5B | $4.5B | $2.9B | $2.2B | $2.8B | $2.8B |
| Enterprise Value | $4.8B | $3.8B | $5.7B | $8.5B | $9.0B | $7.0B | $7.3B | $6.1B | $5.4B | $6.0B | $6.1B |
| P/E Ratio → | -2.05 | — | 14.26 | — | 27.62 | 28.90 | — | 26.79 | — | 14.19 | 472.86 |
| P/S Ratio | 0.69 | 0.39 | 1.16 | 2.41 | 2.89 | 2.38 | 2.13 | 1.45 | 0.74 | 1.00 | 1.01 |
| P/B Ratio | 1.05 | 0.60 | 1.14 | 2.45 | 2.60 | 2.13 | 2.34 | 1.16 | 0.95 | 1.09 | 1.30 |
| P/FCF | — | — | — | 185.10 | 89.28 | 42.50 | 10.07 | 60.50 | 30.90 | 22.65 | 52.69 |
| P/OCF | 17.35 | 9.76 | 28.14 | 15.30 | 19.80 | 14.72 | 6.76 | 8.76 | 5.42 | 7.11 | 7.87 |
P/E links to full P/E history page with 30-year chart
ACHC EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Acadia Healthcare Company, Inc.'s enterprise value stands at 8.3x EBITDA, 27% below its 5-year average of 11.4x. The Healthcare sector median is 14.2x, placing the stock at a 41% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.15 | 1.79 | 2.90 | 3.44 | 3.03 | 3.51 | 3.02 | 1.79 | 2.12 | 2.16 |
| EV / EBITDA | 8.33 | 6.60 | 8.42 | 13.28 | 15.32 | 13.46 | 16.77 | 8.10 | 9.43 | 10.35 | 10.47 |
| EV / EBIT | 12.40 | — | 12.35 | 149.44 | 20.20 | 19.89 | 21.44 | 19.34 | 21.38 | 13.73 | 13.65 |
| EV / FCF | — | — | — | 222.02 | 106.24 | 54.11 | 16.58 | 125.97 | 74.18 | 47.95 | 112.51 |
ACHC Profitability
Margins and return-on-capital ratios measuring operating efficiency
Acadia Healthcare Company, Inc. earns an operating margin of 11.7%. Operating margins have compressed from 17.3% to 11.7% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -41.4% indicates the company is currently destroying shareholder equity. ROIC of 5.9% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 17.6% | 17.6% | 22.6% | 23.3% | 96.2% | 96.1% | 95.8% | 40.6% | 41.0% | 41.8% | 41.0% |
| Operating Margin | 11.7% | 11.7% | 16.6% | 17.3% | 17.9% | 17.9% | — | 32.9% | 13.7% | 15.4% | 15.8% |
| Net Profit Margin | -33.3% | -33.3% | 8.1% | -0.7% | 10.5% | 8.2% | -32.2% | 5.4% | -5.8% | 7.0% | 0.2% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -41.4% | -41.4% | 8.4% | -0.7% | 10.0% | 8.5% | -30.5% | 4.5% | -7.1% | 8.4% | 0.3% |
| ROA | -19.2% | -19.2% | 4.5% | -0.4% | 5.6% | 3.4% | -10.0% | 1.7% | -2.8% | 3.2% | 0.1% |
| ROIC | 5.9% | 5.9% | 8.2% | 8.8% | 8.3% | 7.0% | — | 8.9% | 5.5% | 5.9% | 7.1% |
| ROCE | 7.5% | 7.5% | 10.6% | 11.2% | 10.4% | 8.7% | — | 10.9% | 7.0% | 7.5% | 9.2% |
ACHC Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Acadia Healthcare Company, Inc. carries a Debt/EBITDA ratio of 4.6x, which is highly leveraged (43% above the sector average of 3.2x). Net debt stands at $2.5B ($2.7B total debt minus $133M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.24 | 1.24 | 0.65 | 0.52 | 0.53 | 0.63 | 1.71 | 1.30 | 1.35 | 1.25 | 1.50 |
| Debt / EBITDA | 4.60 | 4.60 | 3.10 | 2.36 | 2.61 | 3.14 | 7.45 | 4.35 | 5.59 | 5.58 | 5.67 |
| Net Debt / Equity | — | 1.18 | 0.63 | 0.49 | 0.49 | 0.58 | 1.52 | 1.26 | 1.33 | 1.22 | 1.48 |
| Net Debt / EBITDA | 4.37 | 4.37 | 2.99 | 2.21 | 2.45 | 2.89 | 6.59 | 4.21 | 5.50 | 5.46 | 5.57 |
| Debt / FCF | — | — | — | 36.92 | 16.96 | 11.60 | 6.51 | 65.47 | 43.28 | 25.30 | 59.82 |
| Interest Coverage | -6.68 | -6.68 | 3.94 | 0.69 | 6.36 | 4.58 | 2.16 | 1.68 | 1.36 | 2.49 | 2.45 |
ACHC Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.55x means Acadia Healthcare Company, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 0.67x to 1.55x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.55 | 1.55 | 1.00 | 0.67 | 1.30 | 1.22 | 1.93 | 1.17 | 1.08 | 1.25 | 1.25 |
| Quick Ratio | 1.54 | 1.54 | 0.99 | 0.67 | 1.29 | 1.21 | 1.93 | 1.16 | 1.07 | 1.24 | 1.23 |
| Cash Ratio | 0.25 | 0.25 | 0.13 | 0.11 | 0.25 | 0.33 | 0.29 | 0.21 | 0.12 | 0.18 | 0.17 |
| Asset Turnover | — | 0.60 | 0.53 | 0.55 | 0.52 | 0.49 | 0.32 | 0.29 | 0.49 | 0.44 | 0.47 |
| Inventory Turnover | 480.01 | 480.01 | 431.90 | 423.80 | 19.70 | 18.95 | 17.98 | 292.73 | 351.86 | 344.81 | 358.14 |
| Days Sales Outstanding | — | 60.07 | 48.83 | 53.53 | 49.46 | 48.01 | 51.88 | 58.35 | 38.54 | 44.39 | 40.87 |
ACHC Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Acadia Healthcare Company, Inc. returns 2.2% to shareholders annually primarily through share buybacks.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 7.0% | — | 3.6% | 3.5% | — | 3.7% | — | 7.0% | 0.2% |
| FCF Yield | — | — | — | 0.5% | 1.1% | 2.4% | 9.9% | 1.7% | 3.2% | 4.4% | 1.9% |
| Buyback Yield | 2.2% | 3.9% | 0.2% | 0.0% | 0.0% | 0.1% | 0.0% | 0.1% | 0.2% | 0.1% | 0.0% |
| Total Shareholder Yield | 2.2% | 3.9% | 0.2% | 0.0% | 0.0% | 0.1% | 0.0% | 0.1% | 0.2% | 0.1% | 0.0% |
| Shares Outstanding | — | $91M | $92M | $91M | $92M | $91M | $89M | $88M | $87M | $87M | $86M |
Peer Comparison
Compare ACHC with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 ACHCYou | $2B | -2.0 | 8.3 | — | 17.6% | 11.7% | -41.4% | 5.9% | 4.6 |
 UHS | $9B | 6.1 | 5.4 | 10.4 | 90.4% | 11.5% | 21.0% | 12.3% | 2.1 |
 SEM | $2B | 14.0 | 12.1 | 5.4 | 11.5% | 6.1% | 7.3% | 4.8% | 7.8 |
 SGRY | $2B | -23.9 | 10.1 | 9.7 | 23.1% | 11.8% | -2.2% | 4.1% | 7.1 |
 BKD | $3B | -12.3 | 25.6 | — | 20.6% | 0.5% | -308.1% | 0.2% | 17.7 |
 ENSG | $9B | 26.3 | 23.5 | 24.2 | 13.7% | 8.6% | 16.9% | 7.0% | 7.7 |
 HCA | $84B | 13.2 | 8.6 | 10.9 | 41.5% | 15.8% | — | 19.9% | 3.2 |
 THC | $15B | 11.1 | 5.9 | 6.0 | 82.3% | 16.1% | 16.1% | 13.2% | 3.1 |
 CYH | $426M | 0.8 | — | 2.0 | 8.7% | -79.4% | — | -70.1% | — |
 OSCR | $7B | -16.8 | — | 7.0 | 14.4% | -3.4% | -44.4% | — | — |
 CVS | $125B | 70.7 | 14.0 | 16.1 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 15 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
ACHC — Frequently Asked Questions
Quick answers to the most common questions about buying ACHC stock.
What is Acadia Healthcare Company, Inc.'s P/E ratio?
Acadia Healthcare Company, Inc.'s current P/E ratio is -2.0x. The historical average is 32.0x.
What is Acadia Healthcare Company, Inc.'s EV/EBITDA?
Acadia Healthcare Company, Inc.'s current EV/EBITDA is 8.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.5x.
What is Acadia Healthcare Company, Inc.'s ROE?
Acadia Healthcare Company, Inc.'s return on equity (ROE) is -41.4%. The historical average is -2.5%.
Is ACHC stock overvalued?
Based on historical data, Acadia Healthcare Company, Inc. is trading at a P/E of -2.0x. Compare with industry peers and growth rates for a complete picture.
What are Acadia Healthcare Company, Inc.'s profit margins?
Acadia Healthcare Company, Inc. has 17.6% gross margin and 11.7% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does Acadia Healthcare Company, Inc. have?
Acadia Healthcare Company, Inc.'s Debt/EBITDA ratio is 4.6x, indicating high leverage. A ratio above 4x may signal elevated financial risk.